Back to User profile » Dr Alessandro Armuzzi

Papers published by Dr Alessandro Armuzzi:


Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis

Pugliese D, Felice C, Landi R, Papa A, Guidi L, Armuzzi A

Drug, Healthcare and Patient Safety 2016, 8:1-7

Published Date: 3 February 2016

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab

Armuzzi A, Pugliese D, Nardone OM, Guidi L

Drug Design, Development and Therapy 2013, 7:289-296

Published Date: 8 April 2013